113 related articles for article (PubMed ID: 12950984)
1. Ex vivo and extracorporeal perfusion with hDAF pig kidneys.
Luo Y; Levy G; Garcia BM; Yang H; Phillips J; Noble L; Chakrabarti S; Grant D; Zhong R
Xenotransplantation; 2003 Sep; 10(5):410-21. PubMed ID: 12950984
[TBL] [Abstract][Full Text] [Related]
2. HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood.
Luo Y; Levy G; Ding J; Qi J; Chakbrati S; Garcia BM; Phillips MJ; Kumar N; Friend P; Noble L; Macdonald J; Zhong R; Grant D
Xenotransplantation; 2002 Jan; 9(1):36-44. PubMed ID: 12005103
[TBL] [Abstract][Full Text] [Related]
3. The influence of baseline expression of human decay accelerating factor transgene on graft survival and acute humoral xenograft rejection.
Sun H; Chen G; Liu W; Kubelik D; Yang H; White DJ; Zhong R; Garcia B
Transplantation; 2005 Nov; 80(9):1331-9. PubMed ID: 16314803
[TBL] [Abstract][Full Text] [Related]
4. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors.
Schuurman HJ; Pino-Chavez G; Phillips MJ; Thomas L; White DJ; Cozzi E
Transplantation; 2002 Apr; 73(7):1146-51. PubMed ID: 11965048
[TBL] [Abstract][Full Text] [Related]
5. Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood.
Storck M; Abendroth D; Prestel R; Pino-Chavez G; Müller-Höker J; White DJ; Hammer C
Transplantation; 1997 Jan; 63(2):304-10. PubMed ID: 9020335
[TBL] [Abstract][Full Text] [Related]
6. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.
Ramirez P; Chavez R; Majado M; Munitiz V; Muñoz A; Hernandez Q; Palenciano CG; Pino-Chavez G; Loba M; Minguela A; Yelamos J; Gago MR; Vizcaino AS; Asensi H; Cayuela MG; Segura B; Marin F; Rubio A; Fuente T; Robles R; Bueno FS; Sansano T; Acosta F; Rodriguez JM; Navarro F; Cabezuelo J; Cozzi E; White DJ; Calne RY; Parrilla P
Transplantation; 2000 Oct; 70(7):989-98. PubMed ID: 11045632
[TBL] [Abstract][Full Text] [Related]
7. Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.
Bühler L; Yamada K; Kitamura H; Alwayn IP; Basker M; Appel JZ; Colvin RB; White-Scharf ME; Sachs DH; Robson SC; Awwad M; Cooper DK
Transplantation; 2001 Dec; 72(11):1743-52. PubMed ID: 11740383
[TBL] [Abstract][Full Text] [Related]
8. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
[TBL] [Abstract][Full Text] [Related]
9. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
[TBL] [Abstract][Full Text] [Related]
10. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor.
Pascher A; Poehlein C; Storck M; Prestel R; Mueller-Hoecker J; White DJ; Abendroth D; Hammer C
Transplantation; 1997 Aug; 64(3):384-91. PubMed ID: 9275100
[TBL] [Abstract][Full Text] [Related]
11. Contrast in the efficacy of hDAF mouse hearts between ex vivo perfusion and transplantation into primates.
Verbakel CA; de Bruin RW; Bonthuis F; Jonker M; Dekker S; Marquet RL; IJzermans JN
Xenotransplantation; 2001 Nov; 8(4):284-91. PubMed ID: 11737854
[TBL] [Abstract][Full Text] [Related]
12. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
[TBL] [Abstract][Full Text] [Related]
13. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
14. Reduction of hyperacute rejection and protection of metabolism and function in hearts of human decay accelerating factor (hDAF)-expressing pigs.
Smolenski RT; Forni M; Maccherini M; Bacci ML; Slominska EM; Wang H; Fornasari P; Giovannoni R; Simeone F; Zannoni A; Frati G; Suzuki K; Yacoub MH; Lavitrano M
Cardiovasc Res; 2007 Jan; 73(1):143-52. PubMed ID: 17134686
[TBL] [Abstract][Full Text] [Related]
15. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
[TBL] [Abstract][Full Text] [Related]
16. Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood.
Schröder C; Pfeiffer S; Wu G; Zorn GL; Ding L; Allen C; Harrison RA; White DJ; Azimzadeh AM; Pierson RN
J Heart Lung Transplant; 2003 Dec; 22(12):1365-75. PubMed ID: 14672751
[TBL] [Abstract][Full Text] [Related]
17. Soluble Galalpha(1,3)Gal conjugate combined with hDAF preserves morphology and improves function of cardiac xenografts.
Brandl U; Erhardt M; Michel S; Jöckle H; Burdorf L; Bittmann I; Rössle M; Mordstein V; Brenner P; Hammer C; Reichart B; Schmoeckel M
Xenotransplantation; 2007 Jul; 14(4):323-32. PubMed ID: 17669174
[TBL] [Abstract][Full Text] [Related]
18. Immunopathology of an hDAF transgenic pig model liver xenotransplant into a primate.
Sanchez A; Ramirez P; Pino G; Chavez R; Majado M; Munitiz V; Muñoz A; Palenciano CG; Yelamos J; Rodriguez-Gago M; Pons JA; Parrilla P
Transplant Proc; 2003 Aug; 35(5):2041-2. PubMed ID: 12962888
[TBL] [Abstract][Full Text] [Related]
19. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914.
Lam TT; Hausen B; Boeke-Purkis K; Paniagua R; Lau M; Hook L; Berry G; Higgins J; Duthaler RO; Katopodis AG; Robbins R; Reitz B; Borie D; Schuurman HJ; Morris RE
Xenotransplantation; 2004 Nov; 11(6):517-24. PubMed ID: 15479461
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pigs transgenic for human decay-accelerating factor.
Cozzi E; Tucker AW; Langford GA; Pino-Chavez G; Wright L; O'Connell MJ; Young VJ; Lancaster R; McLaughlin M; Hunt K; Bordin MC; White DJ
Transplantation; 1997 Nov; 64(10):1383-92. PubMed ID: 9392299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
